Protocol · graded by use, three uses
Pneumatic Compression (sequential)
Venous thromboembolism prevention.
Pneumatic compression uses air-filled sleeves that squeeze the legs in turn. Its strongest use is in the hospital. In patients who could not move, such as after a stroke or brain surgery, it cut blood clots in the legs. That benefit was seen when no blood thinner was given. For limb swelling from lymph fluid, a review found limbs shrank, though small studies disagree on how much it adds. Recovery boots for athletes eased reported soreness but did not improve performance. It is not suited to a leg with an existing clot, an open wound or failing heart.
The A belongs to one of the three uses graded on this record. The other two carry their own letters.
This record carries a separate letter for each thing it has been measured on. The headline grade is the best of them, and it does not transfer to the others.
Intermittent pneumatic compression reduces venous thromboembolism, a hard clinical endpoint An outcome that matters directly to a person and is counted without judgment, such as death, heart attack, stroke or fracture., in randomized trials (Ho et al., Circulation, 2013; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 23852609).
A systematic review A review that searches for every study on a question using a method set in advance, then assesses them together. of randomized trials in lower-extremity lymphedema found objective limb-volume reduction (O'Donnell et al., J Vasc Surg Venous Lymphat Disord, 2026; PMID 41997536). Three randomized trials in breast-cancer-related upper-limb lymphedema disagree on incremental benefit: Szuba et al. (Cancer, 2002; PMID 12436430, n=23) found added volume reduction alongside decongestive therapy, Uzkeser et al. (Breast Cancer, 2015; PMID 23925581, n=31) found none, and Sanal-Toprak et al. (Lymphology, 2019; PMID 31525829, n=46) tested it as a substitute for manual lymphatic drainage rather than showing superiority. Small trials, heterogeneous comparators. Graded B.
Reduces self-reported muscle soreness but does not improve objective neuromuscular performance (Maia et al., 2024, PMID 39416507; Maia et al., 2025, PMID 40555415). Graded C.
Preventing venous thromboembolism in immobilized hospital and surgical patients. Graded separately for clinical lymphedema and for exercise recovery, which carry lower letters.
Why this gradeThe reasoning, and what the grade does not cover.
Grade A by the hard-outcome route: a meta-analysis A study that pools the numbers from several trials into one combined estimate. of randomized trials reporting reduced venous thromboembolism, which is an event rather than a marker (Ho and Tan, Circulation, 2013; PMID 23852609).
WHAT THIS GRADE DOES NOT COVER, AND HERE THE DEVICE ON THE SHELF IS NOT THE DEVICE IN THE TRIALthe A is earned by intermittent pneumatic compression applied to immobilized hospital and surgical patients, to stop clots forming in people who cannot move. It is not a grade for the recovery boots sold to athletes. Those look like the same category, and they are used by people who are walking around, which is the condition the trials were preventing. Exercise recovery and muscle soreness is a separate use on this record, it sits at C, and it rests on self-reported soreness rather than an event. Clinical lymphedema is a third use at B. Three uses, three letters, and the A does not travel between them.
Shared endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score.: Deep vein thrombosis in immobile hospitalized patients, intermittent pneumatic compression versus no compression
- CLOTS 3, University of Edinburgh, UK (Dennis): Proximal DVT 8.5 percent versus 12.1 percent, 2,876 immobile stroke patients. PMID 23727163 · Funding: academic
- McMaster University, Canada (Turpie): DVT 9.0 percent with compression stockings plus pneumatic compression versus 19.8 percent untreated, neurosurgical patients. PMID 2645846 · Funding: academic
What the replication does not cover: The benefit is shown where no anticoagulant is given. Added on top of anticoagulant prophylaxis, pneumatic compression did not reduce VTE in critically ill patients (PREVENT, PMID 30779530). In the Turpie trial, stockings alone did as well as stockings plus compression.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Not to be applied over an acute deep vein thrombosis, severe peripheral arterial disease, active skin infection or an open wound at the site, or decompensated heart failure. The mechanism is the reason: the device moves venous volume centrally, which is the point of it and also what makes those situations unsuitable.
The evidence, in fullSeven papers, each linked to its PubMed record.
See grades_by_use: Grade A for venous thromboembolism prevention (hard endpoint, Ho et al., Circulation, 2013; PMID 23852609); Grade B for clinical lymphedema (O'Donnell et al., J Vasc Surg Venous Lymphat Disord, 2026, PMID 41997536; Szuba et al., Cancer, 2002, PMID 12436430; Uzkeser et al., Breast Cancer, 2015, PMID 23925581; Sanal-Toprak et al., Lymphology, 2019, PMID 31525829); Grade C for exercise recovery (self-reported soreness only; Maia et al. 2024 PMID 39416507, 2025 PMID 40555415).
Limb circumference measurements at baseline and after each 4-week block to quantify lymphedema or edema reduction. For recovery applications, document delayed-onset muscle soreness (DOMS) scores and time-to-performance-recovery across training blocks. Subjective heaviness and fatigue in the affected limb are valid secondary endpoints An outcome a trial also measures but did not choose as its main test. given the population studied.
Evidence notes: meta-analysis, randomized trial
Endpoint graded: Venous thromboembolism incidence (hard)
Last reviewed: July 2026
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
As studiedDose, form, population and duration for every use.
Home compression boots are sold for recovery and circulation. This grade describes in-hospital clot prevention in immobile patients only; it says nothing about home or athletic use, which is graded separately on this record.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
Educational use only · Not medical advice · © Evidence Based Longevity, Inc. All rights reserved · Privacy · Disclosure · Terms · Accessibility
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →